Literature DB >> 25422336

Antiviral treatment of a boy with EBV-associated hydroa vacciniforme.

Anja Pahlow Mose1, Niels Fisker2, Ole Clemmensen3, Anette Bygum1.   

Abstract

Hydroa vacciniforme is one of the rarest forms of photosensitivity disorders of the skin. Effective treatment options are scarce and mainly constitute of strict sun protection. Lately, hydroa vacciniforme has been associated with Epstein-Barr virus infection. We present a patient with hydroa vacciniforme and concomitant previous/chronic Epstein-Barr virus infection. In this case, antiviral treatment was successful. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25422336      PMCID： PMC4244348          DOI： 10.1136/bcr-2014-206488

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  13 in total

1.  Familial hydroa vacciniforme.

Authors:  G Gupta; M Mohamed; D Kemmett
Journal:  Br J Dermatol       Date:  1999-01       Impact factor: 9.302

2.  Atypical hydroa vacciniforme in childhood: from a smoldering stage to Epstein-Barr virus-associated lymphoid malignancy.

Authors:  K Iwatsuki; M Ohtsuka; H Akiba; F Kaneko
Journal:  J Am Acad Dermatol       Date:  1999-02       Impact factor: 11.527

3.  Efficacy of ω-3 polyunsaturated fatty acids for the treatment of refractory hydroa vacciniforme.

Authors:  Frédérique Durbec; Ziad Reguiaï; Fabienne Léonard; Michel Pluot; Philippe Bernard
Journal:  Pediatr Dermatol       Date:  2011-10-04       Impact factor: 1.588

4.  Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.

Authors:  L Verneuil; S Gouarin; F Comoz; F Agbalika; C Creveuil; M Varna; A Vabret; A Janin; D Leroy
Journal:  Br J Dermatol       Date:  2010-03-29       Impact factor: 9.302

5.  Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.

Authors:  Yoji Hirai; Takenobu Yamamoto; Hiroshi Kimura; Yoshinori Ito; Kazuhide Tsuji; Tomoko Miyake; Shin Morizane; Daisuke Suzuki; Kazuyasu Fujii; Keiji Iwatsuki
Journal:  J Invest Dermatol       Date:  2012-02-02       Impact factor: 8.551

6.  The association of latent Epstein-Barr virus infection with hydroa vacciniforme.

Authors:  K Iwatsuki; Z Xu; M Takata; M Iguchi; M Ohtsuka; H Akiba; Y Mitsuhashi; H Takenoshita; R Sugiuchi; H Tagami; F Kaneko
Journal:  Br J Dermatol       Date:  1999-04       Impact factor: 9.302

7.  Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.

Authors:  Keiji Iwatsuki; Masataka Satoh; Takenobu Yamamoto; Takashi Oono; Shin Morizane; Mikio Ohtsuka; Zi-Gang Xu; Daisuke Suzuki; Kazuhide Tsuji
Journal:  Arch Dermatol       Date:  2006-05

8.  EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

Authors:  Hiroshi Kimura; Yoshinori Ito; Shinji Kawabe; Kensei Gotoh; Yoshiyuki Takahashi; Seiji Kojima; Tomoki Naoe; Shinichi Esaki; Atsushi Kikuta; Akihisa Sawada; Keisei Kawa; Koichi Ohshima; Shigeo Nakamura
Journal:  Blood       Date:  2011-11-16       Impact factor: 22.113

9.  Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma.

Authors:  Leticia Quintanilla-Martinez; Cecilia Ridaura; Florian Nagl; Marimar Sáez-de-Ocariz; Carola Durán-McKinster; Ramon Ruiz-Maldonado; Georgia Alderete; Peter Grube; Carmen Lome-Maldonado; Irina Bonzheim; Falko Fend
Journal:  Blood       Date:  2013-08-27       Impact factor: 22.113

10.  Antiviral therapy in children with hydroa vacciniforme.

Authors:  Josefin Lysell; Desiree Wiegleb Edström; Annika Linde; Göran Carlsson; Johan Malmros-Svennilson; Anders Westermark; Jan Andersson; Carl-Fredrik Wahlgren
Journal:  Acta Derm Venereol       Date:  2009       Impact factor: 4.437
View more
  3 in total

1.  Combining an antiviral with rituximab in EBV-related haemophagocytic lymphohistiocytosis led to rapid viral clearance; and a comprehensive review.

Authors:  Christos Stefanou; Christiana Tzortzi; Fotini Georgiou; Chrystalla Timiliotou
Journal:  BMJ Case Rep       Date:  2016-12-09

2.  Recurrent scarring papulovesicular lesions on sun-exposed skin in a 22-year-old man.

Authors:  Melissa A Levoska; Jeffrey I Cohen; Irini Manoli; Chyi-Chia Richard Lee; Steven S T Ching; Jessica Shand; Deborah Tamura; Kenneth H Kraemer; John J DiGiovanna
Journal:  J Am Acad Dermatol       Date:  2017-09-28       Impact factor: 11.527

Review 3.  Hydroa Vacciniforme and Hydroa Vacciniforme-Like Lymphoproliferative Disorder: A Spectrum of Disease Phenotypes Associated with Ultraviolet Irradiation and Chronic Epstein-Barr Virus Infection.

Authors:  Chien-Chin Chen; Kung-Chao Chang; L Jeffrey Medeiros; Julia Yu-Yun Lee
Journal:  Int J Mol Sci       Date:  2020-12-07       Impact factor: 5.923
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.